Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Download PDF
Dtsch Med Wochenschr 2006; 131(33): 1809-1812
DOI: 10.1055/s-2006-949159
DOI: 10.1055/s-2006-949159
Prinzip & Perspektive | Review article
Onkologie/Grundlagenforschung© Georg Thieme Verlag KG Stuttgart · New York
Identifizierung von Tumorantigenen: Strategien und Perspektiven
Identification of tumor antigens: strategies and perspectivesFurther Information
Publication History
eingereicht: 1.3.2006
akzeptiert: 18.5.2006
Publication Date:
11 August 2006 (online)
Schlüsselwörter
Tumorantigen - Immuntherapie - tumorspezifische Immunantwort
Key words
tumor antigen - immuntherapy - tumor-specific immune response
Literatur
- 1
Jäger D, Taverna C, Zippelius A, Knuth A.
Identification of tumor antigens as potential target antigens for immunotherapy by
serological expression cloning.
Cancer Immunol Immunother.
2004;
53
144-147
MissingFormLabel
- 2
Boon T, Coulie P G, Van den Eynde B.
Tumor antigens recognized by T cells.
Immunology Today.
1997;
18
267-268
MissingFormLabel
- 3
Simpson A JG, Caballero O L, Jungbluth A, Chen Y T, Old L J.
Cancer/testis antigens, gametogenesis and cancer.
Nat Rev Cancer.
2005;
5
615-625
MissingFormLabel
- 4
Jäger E, Jager D, Knuth A.
Antigen-specific immunotherapy and cancer vaccines.
Int J Cancer.
2003;
160
817-820
MissingFormLabel
- 5
Zippelius A, Batard P, Rubio-Godoy V. et al .
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state
of local functional tolerance.
Cancer Res.
2004;
64
2865-2873
MissingFormLabel
Dr. med. Alfred Zippelius
Klinik und Poliklinik für Onkologie, Departement für Innere Medizin, UniversitätsSpital
Zürich
Rämistraße 100
CH-8091 Zürich
Phone: 0041/44/2559414
Fax: 0041/44/2554548
Email: alfred.zippelius@usz.ch